Transgene Biotek Ltd

TRABI
Health CareHealthcare
SmallcapWith a market cap of ₹31 cr, stock is ranked 2,632
Moderate RiskStock is 2.98x as volatile as Nifty
4.150.08 (+1.97%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CareHealthcare
SmallcapWith a market cap of ₹31 cr, stock is ranked 2,632
Moderate RiskStock is 2.98x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
-3.00
PB RatioPB Ratio
1.41
Dividend YieldDiv. Yield
Sector PESector PE
38.74
Sector PBSector PB
5.18
Sector Div YldSctr Div Yld
0.66%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Transgene Biotek is a biotechnology company which operates transgene medical centers. Its portfolio of products includes oncology, auto-immunity, drug delivery and biogenerics

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

20182019202020217.492.110.180.44-6.43-8.78-10.96-10.43
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Result 
Announced OnNov 12, 2021

Transgene Biotek Ltd - 526139 - Board Meeting Outcome for Outcome Of Board Meeting. | Download

Transgene Biotek Ltd - 526139 - Board Meeting Outcome for Outcome Of Board Meeting. | Download

Result 
Announced OnNov 12, 2021

TRANSGENE BIOTEK LTD. - 526139 - Board Meeting Outcome for Outcome Of Board Meeting. | Download

TRANSGENE BIOTEK LTD. - 526139 - Board Meeting Outcome for Outcome Of Board Meeting. | Download

Board Meeting 
Announced OnNov 3, 2021

Transgene Biotek Ltd - 526139 - Board Meeting Intimation for This Is To Inform You That A Meeting Of The Board Of Directors Will Be Held On Friday, 12Th November 2021 At 11.00 Am. | Download

Transgene Biotek Ltd - 526139 - Board Meeting Intimation for This Is To Inform You That A Meeting Of The Board Of Directors Will Be Held On Friday, 12Th November 2021 At 11.00 Am. | Download

See all events